Point72 (Difc) LTD Acadia Pharmaceuticals Inc Transaction History

Point72 (Difc) LTD

$2.64 Trillion
Q2 2025

A detailed history of Point72 (Difc) LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Point72 (Difc) LTD holds 9,764 shares of ACAD stock, worth $212,855. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,764

Previous 4,225 131.1%

Holding current value

$212,855

Previous $70.2 Million 200.11%

% of portfolio

0.01%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$14.1 - $22.95 $78,099 - $127,120	5,539 Added 131.1%	9,764 $211 Million
Q1 2025 May 15, 2025	SELL	$16.61 - $20.29 $653,935 - $798,817	-39,370 Reduced 90.31%	4,225 $70.2 Million
Q4 2024 Feb 14, 2025	BUY	$14.29 - $18.76 $622,972 - $817,842	43,595 New	43,595 $800 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $1.11 Million - $1.4 Million	-76,131 Reduced 98.41%	1,232 $20 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.38 Million - $2.39 Million	77,363 New	77,363 $1.43 Billion

Others Institutions Holding ACAD

# of Institutions

346

Shares Held

165M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.53B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.

Account